Earnings Feed
Start Free
BIOJECT MEDICAL TECHNOLOGIES INC·4

Jan 28, 9:14 PM ET

Logomasini Mark 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jan 28, 2013

Insider Transaction Report

Form 4
Period: 2013-01-28
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
Logomasini Mark
Director
Transactions
  • Purchase

    Warrant to Purchase Common Stock

    2011-12-29+39,474→ 78,948 total
    Exercise: $0.19From: 2011-12-29Exp: 2014-06-28→ BJCT Common Stock (39,474 underlying)
  • Purchase

    Series H Convertible Preferred Stock

    2013-01-24$0.04/sh+3,192,285$111,730→ 3,192,285 total
    Exercise: $0.04From: 2013-01-24→ BJCT Common Stock (3,192,285 underlying)
  • Disposition to Issuer

    Warrant to Purchase Common Stock

    2013-01-24−78,948→ 0 total
    Exercise: $0.19From: 2013-01-24Exp: 2013-01-24→ BJCT Common Stock (78,948 underlying)
Footnotes (3)
  • [F1]Cancellation of Warrants pursuant to Convertible Debt conversion into 8,673 Series H Preferred Stock.
  • [F2]No expiration date.
  • [F3]Holdings: 11,173 shares of Series H Preferred Stock convertible into 3,192,285 shares of Common Stock.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT